🔎 Trials Near Me

Utama › Rintangan Insulin › Maryland

Kajian klinikal Rintangan Insulin di Maryland

7 kajian untuk Rintangan Insulin sedang mencari peserta di lokasi di Maryland.

Bandar di Maryland

Teks kajian rasmi (Bahasa Inggeris)

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

  • National Institute of Aging, Clinical Research Unit, Baltimore
Mengambil peserta
Umur 55 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06274749

Tirzepatide for Treatment of CCCA

  • Johns Hopkins Outpatient Center, Baltimore
  • Medical Pavilion at Howard County, Columbia
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07734870

Taste Bud-Derived Stem Cells in Humans

  • National Institute of Aging, Clinical Research Unit, Baltimore
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 120 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT03366168

Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes

  • Johns Hopkins Community Physicians Frederick, Frederick
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07553325

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  • Baltimore VA Medical Center Univ of Maryland, Baltimore
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599982

Genetic Studies of Insulin and Diabetes

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
6 Months – 120 Years · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT00001987

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05470504

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.